Advanced Sterilization Products (ASP) has awarded the Association for the Healthcare Environment (AHE) an Education Grant
The Compendium will be titled, “The Role of the Healthcare Environment in the Transmission of Infection.”
April 25, 2013 -- FOR IMMEDIATE RELEASE
Chicago, April 25, 2013 - The Association for the Healthcare Environment of the American Hospital Association is the recipient of an education grant from Advanced Sterilization Products (ASP) to conduct a comprehensive literature review related to cleaning and surface disinfection for the purpose of developing a compendium of the most current studies. The Compendium will be titled, “The Role of the Healthcare Environment in the Transmission of Infection.”
AHE will identify and compile the literature from studies and trials that provide evidence of the impact of environmental factors on the transmission of infection. The literature also will serve as a guide to conduct an analysis of new research that will be useful to train staff and to drive ongoing cleaning and surface disinfection practice changes for continued performance excellence. The Compendium also will provide the foundation for development of new evidence-based environmental hygiene and infection prevention educational materials appropriate for use across all care settings.
“Pulling together past research into a compendium will help AHE fill the gaps with new research and strategies to drive changes on the ground,” said Patti Costello, AHE Executive Director. “The strategy most relevant to AHE and its members is to utilize evidence-based practices to improve quality and patient safety. We’ve developed the Compendium to share with our members strategies to address changes in the healthcare delivery system.”
“It is AHE’s goal to use the Compendium to identify areas where we will be most helpful to members navigating change, as well as to partner with AHA and other organizations,” said Mike Bailey CHESP, AHE’s president. “AHE is very pleased to collaborate with ASP on this important initiative and we look forward to launching the Compendium in the fall.”
Related news
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
-
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways. “We are very excited to receive this patent, which covers key innovations in the use of blood volume analysis to optimally guide fluid...
Customer comments
No comments were found for Advanced Sterilization Products (ASP) has awarded the Association for the Healthcare Environment (AHE) an Education Grant. Be the first to comment!